Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Yan

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 29, 2019
[Observation on the efficacy of consolidation chemotherapy combined with allogeneic natural killer cell infusion in the treatment of low and moderate risk acute myeloid leukemia]C J Wang, X J Huang, L Z Gong, et al.
Bone Marrow Transplantation|January 20, 2015
A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCTY-Q Sun, L-P Xu, X-H Zhang, et al.
Biomedical and Environmental Sciences : BES|March 1, 1997
Umbilical cord blood lead levels in Shanghai, ChinaX M Shen, C H Yan, D Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[Clinical significance of Epstein-Barr Virus detection in the cerebrospinal fluid of patients who underwent hematopoietic stem cell transplantation]Y He, R Ma, H F Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 19, 2024
[Clinical analysis of 8 cases of refractory hematopoietic reconstitution after haploid hematopoietic stem cell transplantation treated with purified donor CD34-selected hematopoietic stem cells]Y He, R Ma, H F Wang, et al.
Bone Marrow Transplantation|November 1, 2016
Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantationY-R Ma, L-P Xu, X-H Zhang, et al.
Bone Marrow Transplantation|July 30, 2013
Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemiaD-H Liu, L-P Xu, K-Y Liu, et al.
Bone Marrow Transplantation|November 12, 2014
Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndromeX-D Mo, L-P Xu, X-H Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 16, 2024
[Prognostic analysis of 8 patients with hepatic adenoma undergoing allogeneic hematopoietic stem cell transplantation]Y He, Z L Xu, R Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 31, 2025
[Clinical analysis of donor-purified CD34(+) stem cell boost in 11 patients with poor hematopoietic reconstruction after haploid hematopoietic stem cell transplantation for aplastic anemia]Y He, Z L Xu, H Chen, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 29, 2019
[Observation on the efficacy of consolidation chemotherapy combined with allogeneic natural killer cell infusion in the treatment of low and moderate risk acute myeloid leukemia]C J Wang, X J Huang, L Z Gong, et al.
Bone Marrow Transplantation|January 20, 2015
A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCTY-Q Sun, L-P Xu, X-H Zhang, et al.
Biomedical and Environmental Sciences : BES|March 1, 1997
Umbilical cord blood lead levels in Shanghai, ChinaX M Shen, C H Yan, D Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2023
[Clinical significance of Epstein-Barr Virus detection in the cerebrospinal fluid of patients who underwent hematopoietic stem cell transplantation]Y He, R Ma, H F Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 19, 2024
[Clinical analysis of 8 cases of refractory hematopoietic reconstitution after haploid hematopoietic stem cell transplantation treated with purified donor CD34-selected hematopoietic stem cells]Y He, R Ma, H F Wang, et al.
Bone Marrow Transplantation|November 1, 2016
Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantationY-R Ma, L-P Xu, X-H Zhang, et al.
Bone Marrow Transplantation|July 30, 2013
Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemiaD-H Liu, L-P Xu, K-Y Liu, et al.
Bone Marrow Transplantation|November 12, 2014
Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndromeX-D Mo, L-P Xu, X-H Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 16, 2024
[Prognostic analysis of 8 patients with hepatic adenoma undergoing allogeneic hematopoietic stem cell transplantation]Y He, Z L Xu, R Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 31, 2025
[Clinical analysis of donor-purified CD34(+) stem cell boost in 11 patients with poor hematopoietic reconstruction after haploid hematopoietic stem cell transplantation for aplastic anemia]Y He, Z L Xu, H Chen, et al.
Pageof 15